Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Olfactory transduction | R-HSA-9751605 | map04740 | santonin | 3055 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | santonin | 3055 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | santonin | 3055 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | quinethazone | 667477 | drug-path |
Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | quinethazone | 667477 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | quinethazone | 667477 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | quinethazone | 667477 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | quinethazone | 667477 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | quinethazone | 667477 | drug-path |
T cell receptor signaling pathway | R-HSA-983705 | map04660 | quinethazone | 667477 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | quinethazone | 667477 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | rifabutin | 3585 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | rifabutin | 3585 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | rifabutin | 3585 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | rifabutin | 3585 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | rifabutin | 3585 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | rifabutin | 3585 | drug-path |
Tight junction | R-HSA-2134514 | map04530 | rifabutin | 3585 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | rifabutin | 3585 | drug-path |
Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | rifabutin | 3585 | drug-path |